JCM | Free Full-Text | The Use of Tocilizumab in Patients with COVID-19: A Systematic Review, Meta-Analysis and Trial Sequential Analysis of Randomized Controlled Studies
The sequence of disease-modifying anti-rheumatic drugs: pathways to and predictors of tocilizumab monotherapy | Arthritis Research & Therapy | Full Text
Tocilizumab Effect in COVID-19 Hospitalized Patients: A Systematic Review and Meta-Analysis of Randomized Control Trials
Comparison of the two tocilizumab strategies used in the economic... | Download Scientific Diagram
TropicalMed | Free Full-Text | Treatment of Severe COVID-19 with Tocilizumab Mitigates Cytokine Storm and Averts Mechanical Ventilation during Acute Respiratory Distress: A Case Report and Literature Review
Health Product InfoWatch: October 2022 - Canada.ca
Sequence coverage of the heavy chain and light chain of originator... | Download Scientific Diagram
The Role of Tocilizumab in Cytokine Storm and Improving Outcomes in COVID-19 | Bentham Science
Comparing the efficacy of tocilizumab with corticosteroid therapy in treating COVID-19 patients: a systematic review and meta-analysis | SpringerLink
Actemra® 20 mg/mL, concentrate for solution for intravenous (IV) infusion
Measuring IL-6 and sIL-6R in serum from patients treated with tocilizumab and/or siltuximab following CAR T cell therapy - ScienceDirect
Frontiers | Single-Cell RNA Sequencing of Tocilizumab-Treated Peripheral Blood Mononuclear Cells as an in vitro Model of Inflammation
Cureus | High-Dose Dexamethasone Versus Tocilizumab in Moderate to Severe COVID-19 Pneumonia: A Randomized Controlled Trial | Article
LncRNA MIR31HG is induced by tocilizumab and ameliorates rheumatoid arthritis fibroblast-like synoviocyte-mediated inflammation via miR-214-PTEN-AKT signaling pathway | Aging
Unravelling the potentialities of tocilizumab for the development of a potential immunotherapeutic regimen against COVID-19—A narrative review
Effect of tocilizumab on clinical outcomes at 15 days in patients with severe or critical coronavirus disease 2019: randomised controlled trial | The BMJ
Tocilizumab does not block interleukin-6 (IL-6) signaling in murine cells | PLOS ONE
Frontiers | Tocilizumab and COVID-19: Timing of Administration and Efficacy
Interleukin-6 blockade with tocilizumab increases Tregs and reduces T effector cytokines in renal graft inflammation: A randomized controlled trial - American Journal of Transplantation
Tocilizumab: Uses, Interactions, Mechanism of Action | DrugBank Online
Pharmaceutics | Free Full-Text | Effects of Tocilizumab on Inflammation and Iron Metabolism in Critically Ill Patients with COVID-19
Effective treatment of severe COVID-19 patients with tocilizumab | PNAS
Tocilizumab plus dexamethasone versus dexamethasone in patients with moderate-to-severe COVID-19 pneumonia: A randomised clinical trial from the CORIMUNO-19 study group - eClinicalMedicine
Tocilizumab Effect in COVID-19 Hospitalized Patients: A Systematic Review and Meta-Analysis of Randomized Control Trials
Tocilizumab among patients with COVID-19 in the intensive care unit: a multicentre observational study - The Lancet Rheumatology
Sequence coverage of the heavy chain and light chain of originator... | Download Scientific Diagram
Rituximab versus tocilizumab in rheumatoid arthritis: synovial biopsy-based biomarker analysis of the phase 4 R4RA randomized trial | Nature Medicine
